Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure

Journal of Cardiovascular Pharmacology

Volumn 49, Issue 6, 2007, Pages 394-400

  Eguchi, Kazuo ^a,b   Tomizawa, Hidenori ^b   Ishikawa, Joji ^b   Hoshide, Satoshi ^b   Fukuda, Toshio ^c   Numao, Toshio ^d   Shimada, Kazuyuki ^b   Kario, Kazuomi ^b  

^a Department of Medicine   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Nasu Chuoh Hospital   (Japan)

^d Shioya General Hospital   (Japan)

Author keywords

Ambulatory blood pressure; Amlodipine; Azelnidipine; Baroreflex sensitivity

Indexed keywords

AMLODIPINE; AZELNIDIPINE; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VALSALVA MANEUVER;

ADULT; AGED; AGED, 80 AND OVER; AMLODIPINE; AZETIDINECARBOXYLIC ACID; BAROREFLEX; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 34347219753     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31804d1cf1     Document Type: Article

References (44)

1. Chapleau Mark W. Arterial baroreflexes. In: Izzo JL, Black HR, eds. Hypertension Primer: The Essentials of High Blood Pressure. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2003:103-106.
2. Ketch T, Biaggioni I, Robertson R, et al. Four faces of baroreflex failure: hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia. Circulation. 2002;105:2518-2523.
3. Parati G, Di Rienzo M, Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens. 2000;18:7-19.
4. Parati G, Mutti E, Frattola A, et al. Beta-adrenergic blocking treatment and 24-hour baroreflex sensitivity in essential hypertensive patients. Hypertension. 1994;23(6 Pt 2):992-996.
5. Chen X HM, Jones JV, Sleight P, et al. Baroreflex sensitivity and the blood pressure response to beta-blockade. J Hum Hypertens. 1999;13:185-190.
6. Chern C, Hsu H, Hu H, et al. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension. J Cardiovasc Pharmacol. 2006;47:169-174.
7. James MA, Rakicka H, Panerai RB, et al. Baroreflex sensitivity changes with calcium antagonist therapy in elderly subjects with isolated systolic hypertension. J Hum Hypertens. 1999;13:87-95.
8. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
9. Eguchi K, Kario K, Hoshide Y, et al. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens. 2004;17:112-117.
10. Dahlof B, Sever P, Poulter N, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895-906.
11. Eguchi K, Kario K, Shimada K. Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients. Hypertens Res. 2002;25:329-333.
12. Kuramoto K, Ichikawa S, Hirai A, et al. Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure. Hypertens Res. 2003;26:201-208.
13. Gillman MW, Kannel WB, Belanger A, et al. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J. 1993;125:1148-1154.
14. Arita M, Hashizume T, Tanigawa K, et al. A new Ca-antagonist, azelnidipine, reduced blood pressure during exercise without augmentation of sympathetic nervous system in essential hypertension: a randomized, double-blind, placebo-controlled trial. J Cardiovasc Pharmacol. 1999;33:186-192.
15. Eguchi K, Kario K, Shimada K. Effects of long-acting ACE inhibitor (temocapril) and long-acting Ca channel blocker (amlodipine) on 24-h ambulatory BP in elderly hypertensive patients. J Hum Hypertens. 2001;15:643-648.
16. Robbe HW, Mulder LJ, Ruddel H, et al. Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension. 1987;10:538-543.
17. Palmero H, Caeiro T, Iosa D, et al. Baroreceptor reflex sensitivity index derived from Phase 4 of the Valsalva maneuver. Hypertension. 1981;3:II134-II137.
18. Kario K, Shimada K, Schwartz JE, et al. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol. 2001;38:238-245.
19. Kario K, Pickering TG, Matsuo T, et al. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852-857.
20. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401-1406.
21. Matsui Y, Kario K, Ishikawa J, et al. Smoking and antihypertensive medication: interaction between blood pressure reduction and arterial stiffness. Hypertens Res. 2005;28:631-638.
22. Cortez-Cooper MY, Supak JA, Tanaka H. A new device for automatic measurements of arterial stiffness and ankle-brachial index. Am J Cardiol. 2003;91:1519-1522.
23. Ferrari A, Gregorini L, Ferrari MC, et al. Digitalis and baroreceptor reflexes in man. Circulation. 1981;63:279-285.
24. Ferguson DW. Influence of nifedipine on arterial baroreflex modulation of heart rate control during dynamic increases in arterial pressure: studies in normal man. Am Heart J. 1987;114(4 Pt 1):773-781.
25. Hirsch AT, Dzau VJ, Cutler SS, et al. Effect of isradipine on cardiopulmonary baroreflex function, regional blood flow, and vascular responsiveness in hypertensive patients. J Cardiovasc Pharmacol. 1992;19:272-281.
26. Tomiyama H, Kimura Y, Sakuma Y, et al. Effects of an ACE inhibitor and a calcium channel blocker on cardiovascular autonomic nervous system and carotid distensibility in patients with mild to moderate hypertension. Am J Hypertens. 1998;11:682-689.
27. Kumagai H, Suzuki H, Matsumura Y, et al. Differential effects of captopril and nicardipine on baroreflex control of sympathetic nerve activity and heart rate in renal hypertension. J Hypertens. 1992;10:1485-1491.
28. Minami J, Kawano Y, Makino Y, et al. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Br J Clin Pharmacol. 2000;50:615-620.
29. Shokoji T, Fujisawa Y, Kiyomoto H, et al. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats. Hypertens Res. 2005;28:1017-1023.
30. Shinomiya K, Mizushige K, Fukunaga M, et al. Antioxidant effect of a new calcium antagonist, azelnidipine, in cultured human arterial endothelial cells. J Int Med Res. 2004;32:170-175.
31. Yamagishi S, Inagaki Y, Nakamura K, et al. Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties. J Cardiovasc Pharmacol. 2004;43:724-730.
32. Ruilope LM, Heintz D, Brandao AA, et al. 24-hour ambulatory blood-pressure effects of valsartan & hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: A VAST sub-study. Blood Press Monit. 2005;10:85-91.
33. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001;285:2719-2728.
34. Tatti P, Pahor M, Byington RP, et al. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care. 1998;21:597-603.
35. Lefrandt JD, Heitmann J, Sevre K, et al. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE Study. Am J Hypertens. 2001;14:1083-1089.
36. Vaile JC, Jordan PJ, Stallard TJ, et al. The effects of acute and chronic dihydropyridine calcium antagonist therapy on baroreflex sensitivity: a re-analysis using the sequence method. J Hum Hypertens. 2000;14:189-194.
37. Kuwajima I, Abe K, Group J-MS, et al. Effects of the long-acting calcium channel blocker barnidipine hydrochloride on 24-h ambulatory blood pressure. Blood Press Monit. 2002;7:63-55.
38. Nichols WW, O'Rourke MF. Properties of the arterial wall: theory. McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles. London: Arnold; 2005:63-64.
39. Nakamura K, Yamagishi S, Inoue H. Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist. Med Hypotheses. 2005;65:155-157.
40. Trion A, de Maat M, Jukema W, et al. Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/ hCRP transgenic mice. J Cardiovasc Pharmacol. 2006;47:89-95.
41. Yoshii T, Iwai M, Li Z, et al. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res. 2006;29:457-466.
42. Morgan T, Lauri J, Bertram D, et al. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17:118-123.
43. Gatzka CD, Cameron JD, Dart AM, et al. Correction of carotid augmentation index for heart rate in elderly essential hypertensives. Am J Hypertens. 2001;14:573-577.
44. Wilkinson IB, MacCallum H, Flint L, et al. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol (Lond). 2000;525:263-270.